Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Monkeypox: EMA starts review for Imvanex 28 Ιούνιος 2022NewsHumanMpoxVaccines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 June 2022 24 Ιούνιος 2022NewsHumanCOVID-19MedicinesReferrals First gene therapy to treat severe haemophilia A 24 Ιούνιος 2022NewsHumanMedicines EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU 23 Ιούνιος 2022NewsHumanCOVID-19Vaccines EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17 23 Ιούνιος 2022NewsHumanCOVID-19Vaccines Global regulators work towards strengthening collaboration on observational research beyond COVID-19 pandemic 20 Ιούνιος 2022NewsHumanCOVID-19 EMA Management Board: highlights of June 2022 meeting 17 Ιούνιος 2022NewsCorporate Start of rolling review for adapted Spikevax COVID-19 vaccine 17 Ιούνιος 2022NewsHumanCOVID-19Vaccines Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 June 2022 17 Ιούνιος 2022NewsVeterinaryMedicines Start of rolling review for adapted Comirnaty COVID-19 vaccine 15 Ιούνιος 2022NewsHumanCOVID-19Vaccines 1 … 44 45 46 47 48 Page 48 of 384 49 50 51 52 … 384
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 June 2022 24 Ιούνιος 2022NewsHumanCOVID-19MedicinesReferrals
EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU 23 Ιούνιος 2022NewsHumanCOVID-19Vaccines
EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17 23 Ιούνιος 2022NewsHumanCOVID-19Vaccines
Global regulators work towards strengthening collaboration on observational research beyond COVID-19 pandemic 20 Ιούνιος 2022NewsHumanCOVID-19
Start of rolling review for adapted Spikevax COVID-19 vaccine 17 Ιούνιος 2022NewsHumanCOVID-19Vaccines
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 June 2022 17 Ιούνιος 2022NewsVeterinaryMedicines
Start of rolling review for adapted Comirnaty COVID-19 vaccine 15 Ιούνιος 2022NewsHumanCOVID-19Vaccines